These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 12816361

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
    Hagiwara Y, McGhee JR, Fujihashi K, Kobayashi R, Yoshino N, Kataoka K, Etani Y, Kweon MN, Tamura S, Kurata T, Takeda Y, Kiyono H, Fujihashi K.
    J Immunol; 2003 Feb 15; 170(4):1754-62. PubMed ID: 12574339
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H, Fujihashi K, Kato R, Yuki Y, McGhee JR.
    J Immunol; 2001 Mar 01; 166(5):3114-21. PubMed ID: 11207263
    [Abstract] [Full Text] [Related]

  • 6. Suppression of specific IgE antibody responses by liposome-conjugated ovalbumin in mice sensitized with ovalbumin via the respiratory tract.
    Yoshikawa T, Uchida T, Naito S, Horino A, Taneichi M, Kato H, Komuro K, Nakano Y, Mori M, Nishinohara S, Chiba J, Kurata T, Tamura S.
    Int Arch Allergy Immunol; 2000 Feb 01; 121(2):108-15. PubMed ID: 10705220
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
    Boyaka PN, Ohmura M, Fujihashi K, Koga T, Yamamoto M, Kweon MN, Takeda Y, Jackson RJ, Kiyono H, Yuki Y, McGhee JR.
    J Immunol; 2003 Jan 01; 170(1):454-62. PubMed ID: 12496431
    [Abstract] [Full Text] [Related]

  • 9. RANTES potentiates antigen-specific mucosal immune responses.
    Lillard JW, Boyaka PN, Taub DD, McGhee JR.
    J Immunol; 2001 Jan 01; 166(1):162-9. PubMed ID: 11123289
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nasal cholera toxin elicits IL-5 and IL-5 receptor alpha-chain expressing B-1a B cells for innate mucosal IgA antibody responses.
    Kataoka K, Fujihashi K, Sekine S, Fukuiwa T, Kobayashi R, Suzuki H, Nagata H, Takatsu K, Shizukuishi S, McGhee JR, Fujihashi K.
    J Immunol; 2007 May 15; 178(10):6058-65. PubMed ID: 17475830
    [Abstract] [Full Text] [Related]

  • 12. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
    Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee JR.
    J Immunol; 2003 Jun 01; 170(11):5636-43. PubMed ID: 12759444
    [Abstract] [Full Text] [Related]

  • 13. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
    Anjuère F, George-Chandy A, Audant F, Rousseau D, Holmgren J, Czerkinsky C.
    J Immunol; 2003 Feb 01; 170(3):1586-92. PubMed ID: 12538724
    [Abstract] [Full Text] [Related]

  • 14. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M, Yasuda Y, Kozuka S, Taniguchi T, Matano K, Maeyama J, Komiya T, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 1999 Nov 12; 18(7-8):743-51. PubMed ID: 10547435
    [Abstract] [Full Text] [Related]

  • 15. Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization.
    Ishii M, Kojima N.
    Glycoconj J; 2010 Jan 12; 27(1):115-23. PubMed ID: 19816665
    [Abstract] [Full Text] [Related]

  • 16. Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens.
    Duverger A, Jackson RJ, van Ginkel FW, Fischer R, Tafaro A, Leppla SH, Fujihashi K, Kiyono H, McGhee JR, Boyaka PN.
    J Immunol; 2006 Feb 01; 176(3):1776-83. PubMed ID: 16424208
    [Abstract] [Full Text] [Related]

  • 17. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
    Saito M, Otake S, Ohmura M, Hirasawa M, Takada K, Mega J, Takahashi I, Kiyono H, McGhee JR, Takeda Y, Yamamoto M.
    J Infect Dis; 2001 Mar 01; 183(5):823-6. PubMed ID: 11181162
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.